Measuring the performance of markers for guiding treatment decisions.
Summary of "Measuring the performance of markers for guiding treatment decisions."
Treatment selection markers, sometimes called predictive markers, are factors that help clinicians select therapies that maximize good outcomes and minimize adverse outcomes for patients. Existing statistical methods for evaluating a treatment selection marker include assessing its prognostic value, evaluating treatment effects in patients with a restricted range of marker values, and testing for a statistical interaction between marker value and treatment. These methods are inadequate, because they give misleading measures of performance that do not answer key clinical questions about how the marker might help patients choose treatment, how treatment decisions should be made on the basis of a continuous marker measurement, what effect using the marker to select treatment would have on the population, or what proportion of patients would have treatment changes on the basis of marker measurement. Marker-by-treatment predictiveness curves are proposed as a more useful aid to answering these clinically relevant questions, because they illustrate treatment effects as a function of marker value, outcomes when using or not using the marker to select treatment, and the proportion of patients for whom treatment recommendations change after marker measurement. Randomized therapeutic clinical trials, in which entry criteria and treatment regimens are not restricted by the marker, are also proposed as the basis for constructing the curves and evaluating and comparing markers.
Affiliation
Fred Hutchinson Cancer Research Center, Seattle, Washington; Academic Medical Center, Amsterdam, the Netherlands; and Cancer Research and Biostatistics, Seattle, Washington.
Journal Details
This article was published in the following journal.
Name: Annals of internal medicine
ISSN: 1539-3704
Pages: 253-9
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/21320940
- DOI: http://dx.doi.org/10.1059/0003-4819-154-4-201102150-00006
Medical and Biotech [MESH] Definitions
Social Control Policies
Decisions for determining and guiding present and future objectives from among alternatives.
Benchmarking
Method of measuring performance against established standards of best practice.
Professional Autonomy
The quality or state of being independent and self-directing, especially in making decisions, enabling professionals to exercise judgment as they see fit during the performance of their jobs.
Practice (psychology)
Performance of an act one or more times, with a view to its fixation or improvement; any performance of an act or behavior that leads to learning.
Supreme Court Decisions
Decisions made by the United States Supreme Court.
PubMed Articles
The effect of a tuberculosis chest X-ray image reference set on non-expert reader performance.
OBJECTIVES: In low-resource settings, limitations in diagnostic accuracy of chest X-rays (CXR) for pulmonary tuberculosis (PTB) relate partly to non-expert interpretation. We piloted a TB CXR Image Re...
Renal artery intervention using a virtual 4.5-Fr guiding catheter.
A 6.5-Fr guiding catheter (Parent Plus 45, Medikit, Tokyo, Japan), composed of a hydrophilic sheathless guiding catheter and a dilator, has recently been developed for the treatment of renal artery st...
Guiding effective decisions: an interview with Matthew Segall, CEO of Optibrium.
Genomic markers to tailor treatments: waiting or initiating?
The decade since the publication of the Human Genome Project draft has ended with the discovery of hundreds of genomic markers related to diseases and phenotypes. However, the project has not yet deli...
When an existing standard marker does not have sufficient classification accuracy on its own, new markers are sought with the goal of yielding a combination with better performance. The primary criter...
Clinical Trials
Measuring Quality of Decisions About Treatment of Depression
The purpose of this randomized controlled trial is to examine the impact of a patient decision aid on the quality of decisions about managing symptoms of depression. In particular, we will...
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
The purpose of this study is to understand how people make decisions about sun protection. This study is important in helping to protect against sun exposure, since it is a main risk facto...
Lung Cancer Informational Study (LCIS)
The purpose of this study is to evaluate a new program to help the patient and the caregiver make decisions about treatment for lung cancer. We need to know if a new information program is...
Endothelial Function in Patients With Sickle Cell Anemia Before and After Sildenafil
The investigators would like to study the endothelial function in sickle cell patients without pulmonary hypertension in an in vivo method during a steady state condition before and after...
Biomarkers for Diagnosis of Lung Nodules
A need exists for non-invasive testing to aid in clinical decision-making for CT scan detected lung nodules of indeterminate etiology. The investigators hypothesize that biomarkers detect...
